NCT02878122已完成不适用
Study of Predictive Factors of Chemoresistance in Ovarian Cancer
Rennes University Hospital1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2015年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 13
- 试验地点
- 1
- 主要终点
- Chemoresistance defined by clinical recurrence
研究概览
简要总结
Epithelial ovarian cancer (EOC) has a poor prognosis. EOC management requires debulking surgery and chemotherapy based on taxol and carboplatine. Initial response is often good, but most often a recurrence occurred in the first 18 months. Early recurrence signs chemoresistance and palliative treatment. The study of predictive clinical or biological factors is required to adapt therapeutic and develop new treatments.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •patient > 18 years of age
- •patient with histological proven epithelial ovarian cancer
排除标准
- •patients who can not give their own consent
- •patients without ovarian cancer
结局指标
主要结局
Chemoresistance defined by clinical recurrence
时间窗: 6 months after the end of chemotherapy
Chemoresistance defined by biological recurrence
时间窗: 6 months after the end of chemotherapy
Chemoresistance defined by radiological recurrence
时间窗: 6 months after the end of chemotherapy
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Molecular Mechanisms Leading to Chemoresistance in Epithelial Ovarian CancerOvarian CancerNCT02758652Tampere University Hospital160
已完成
不适用
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)Ovarian CancerPeritoneal CarcinomaNCT03931304Hospices Civils de Lyon1,200
已完成
不适用
Lavage of the Uterine Cavity for the Diagnosis of Ovarian and Tubal Carcinoma and Their Premalignant Changes.Ovarian Epithelial CancerNCT02062697Medical University of Vienna50
已完成
不适用
Impact of Fas/FasL in Chemotherapy Response in Epithelial Ovarian CarcinomaOvarian CarcinomaNCT02297958Rennes University Hospital28
已完成
不适用
Risk Factors for Anatomic Leakage in Advanced Ovarian Cancer SurgeryIntestinal Anastomotic LeakNCT04604964Catholic University of the Sacred Heart515